Thomas Shrader
Stock Analyst at BTIG
(3.19)
# 1,172
Out of 5,090 analysts
66
Total ratings
46.55%
Success rate
3.03%
Average return
Main Sectors:
Stocks Rated by Thomas Shrader
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $25 | $2.43 | +928.81% | 1 | Dec 3, 2025 | |
| BHVN Biohaven | Reiterates: Buy | $16 | $9.61 | +66.49% | 5 | Nov 18, 2025 | |
| ANRO Alto Neuroscience | Initiates: Buy | $27 | $13.38 | +101.79% | 1 | Nov 17, 2025 | |
| COYA Coya Therapeutics | Maintains: Buy | $15 → $16 | $5.99 | +167.34% | 3 | Nov 13, 2025 | |
| PCVX Vaxcyte | Reiterates: Buy | $85 | $46.28 | +83.68% | 5 | Nov 10, 2025 | |
| ALDX Aldeyra Therapeutics | Reiterates: Buy | $9 | $4.87 | +84.99% | 2 | Nov 10, 2025 | |
| STOK Stoke Therapeutics | Reiterates: Buy | $39 | $30.96 | +25.97% | 2 | Nov 5, 2025 | |
| ACIU AC Immune | Reiterates: Buy | $8 | $2.89 | +176.81% | 3 | Nov 4, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Buy | $48 → $23 | $6.78 | +239.23% | 2 | Oct 22, 2025 | |
| ALEC Alector | Downgrades: Neutral | n/a | $1.21 | - | 4 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $3.48 | +158.99% | 4 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $14 | $5.63 | +148.89% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $63 | $46.85 | +34.47% | 3 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $72 | $72.73 | -1.00% | 1 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.89 | - | 3 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.64 | +144.65% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.87 | - | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $7.52 | +2,561.34% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $60 | $5.04 | +1,091.66% | 1 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $7 | $4.52 | +55.04% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $68 → $13 | $0.85 | +1,423.50% | 3 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $22 | $2.00 | +1,000.00% | 2 | Oct 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $1.30 | +3,823.08% | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $8.31 | +92.54% | 1 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.34 | - | 1 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $20.30 | - | 2 | Oct 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.26 | +137.45% | 3 | Apr 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $397 → $346 | $181.82 | +90.30% | 3 | Feb 21, 2019 |
NRx Pharmaceuticals
Dec 3, 2025
Reiterates: Buy
Price Target: $25
Current: $2.43
Upside: +928.81%
Biohaven
Nov 18, 2025
Reiterates: Buy
Price Target: $16
Current: $9.61
Upside: +66.49%
Alto Neuroscience
Nov 17, 2025
Initiates: Buy
Price Target: $27
Current: $13.38
Upside: +101.79%
Coya Therapeutics
Nov 13, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $5.99
Upside: +167.34%
Vaxcyte
Nov 10, 2025
Reiterates: Buy
Price Target: $85
Current: $46.28
Upside: +83.68%
Aldeyra Therapeutics
Nov 10, 2025
Reiterates: Buy
Price Target: $9
Current: $4.87
Upside: +84.99%
Stoke Therapeutics
Nov 5, 2025
Reiterates: Buy
Price Target: $39
Current: $30.96
Upside: +25.97%
AC Immune
Nov 4, 2025
Reiterates: Buy
Price Target: $8
Current: $2.89
Upside: +176.81%
Arcturus Therapeutics Holdings
Oct 22, 2025
Maintains: Buy
Price Target: $48 → $23
Current: $6.78
Upside: +239.23%
Alector
Oct 22, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.21
Upside: -
Oct 15, 2025
Reiterates: Buy
Price Target: $9
Current: $3.48
Upside: +158.99%
Oct 13, 2025
Maintains: Buy
Price Target: $7 → $14
Current: $5.63
Upside: +148.89%
Sep 29, 2025
Reiterates: Buy
Price Target: $63
Current: $46.85
Upside: +34.47%
Sep 8, 2025
Initiates: Buy
Price Target: $72
Current: $72.73
Upside: -1.00%
Jul 1, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.89
Upside: -
Mar 24, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.64
Upside: +144.65%
Sep 4, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.87
Upside: -
Oct 3, 2023
Initiates: Buy
Price Target: $200
Current: $7.52
Upside: +2,561.34%
Jul 28, 2023
Maintains: Buy
Price Target: $180 → $60
Current: $5.04
Upside: +1,091.66%
May 25, 2023
Maintains: Buy
Price Target: $15 → $7
Current: $4.52
Upside: +55.04%
Mar 28, 2023
Maintains: Buy
Price Target: $68 → $13
Current: $0.85
Upside: +1,423.50%
Oct 5, 2022
Maintains: Buy
Price Target: $15 → $22
Current: $2.00
Upside: +1,000.00%
Apr 20, 2021
Initiates: Buy
Price Target: $51
Current: $1.30
Upside: +3,823.08%
Mar 8, 2021
Initiates: Buy
Price Target: $16
Current: $8.31
Upside: +92.54%
Feb 3, 2021
Downgrades: Neutral
Price Target: n/a
Current: $4.34
Upside: -
Oct 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $20.30
Upside: -
Apr 3, 2020
Maintains: Buy
Price Target: $4 → $3
Current: $1.26
Upside: +137.45%
Feb 21, 2019
Downgrades: Hold
Price Target: $397 → $346
Current: $181.82
Upside: +90.30%